Skip to main content
Featured products
OSYPKA PACE 101H® is a single-chamber external pacemaker ideal for temporary cardiac pacing in…
The ICONCore® is a portable, non-invasive cardiometer that enables continuous measurement of…
Balloon dilatation catheter for percutaneous transluminal valvuloplasty, ideal for TAVI…
CoraSim® is a heart simulator designed for training and education in cardiac electrophysiology…
Temporary myocardial pacing cables intended for use after cardiac surgery. Available in multiple…
The OSYPKA PACE 300® is a three-chamber external pacemaker designed for temporary biventricular…

    Dolphin subintimal entry catheter

    Dolphin is a subintimal entry system designed to facilitate re-entry into the true lumen after subintimal dissection, especially in complex occlusive lesions.

    Dolphin subintimal entry catheter

    Dolphin is a subintimal entry system designed to facilitate re-entry into the true lumen after subintimal dissection, especially in complex occlusive lesions.


    The Dolphin subintimal entry catheter is specifically designed to assist in subintimal dissection and re-entry into the true lumen in cases of chronic total occlusion (CTO) or severely diseased vascular segments.

    It provides controlled access to the subintimal space and precise guidance towards the original lumen, increasing success rates in complex peripheral or coronary interventions.

    Features

    • Dedicated subintimal navigation: specially designed tip enables advancement through the subintimal plane.
    • Re-entry into the true lumen: distal geometry facilitates precise reconnection to the original flow.
    • High pushability and torque control: braided or coiled shaft effectively transmits force.
    • Hydrophilic coating (optional): reduces friction against the vessel wall and minimises the risk of dissection.

    Benefits

    • Higher success rate in subintimal procedures thanks to controlled re-entry.
    • Reduced risk of dissection propagation in compromised vessels.
    • Versatile use in superficial femoral, popliteal, and other peripheral arteries affected by peripheral arterial disease (PAD).